Markers of Antioxidant Defense in Patients with Type 2 Diabetes

Table 1

Demographic and biochemical characteristics of studied patients with type 2 diabetes and controls.

Parameter	Type 2 diabetes	Control group
Age [years]	59.5 ± 11.6	55.2 ± 11
Gender
Women	40 50]	40 51]
Men	40 50]	39 49]
Diabetes duration [years]	8.5 (4.0–12)	—
BMI	31.54 ± 5.73	29.26 ± 8.43
Hypertension	77 [88.7]	—
Obesity (BMI > 30 kg/m^2)	44 55]	32 41]
No complications	38 47.5%]	—
Complications	42 52.5%]	—
Glucose [mmol/L]	6.75 (5.25–9.35)	4.4 (4.0–4.9)
HbA1c [%]; [mmol/mol]	8.5 (7.25–10.0); 69 (56–86)	—
Creatinine [mol/L]	66.8 (58.2–82.0)	—
e-GFR (MDRD) [mL/min/1.73 m^2]	94.8 (75–116.4)	—
TCH [mmol/L]	4.38 (3.82–5.27)	5.06 (4.09–5.9)
LDL [mmol/L]	2.21 (1.81–3.15)	2.94 (2.22–3.75)
HDL [mmol/L]	0.82 (0.71–1.00)	1.29 (1.06–1.24)
TG [mmol/L]	2.55 (1.74–3.75)	1.47 (1.08–1.87)
Albuminuria [mg/L]	2.51 (0.0–8.03)	—

Data are expressed as mean ± SD, median and interquartile range, or percentage of frequency [%], as appropriate.